Eli Lilly and Company (LLY) Earnings History
Annual and quarterly earnings data from 1989 to 2025
Loading earnings history...
LLY EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
LLY Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 83.8% | 45.6% | 31.7% |
| 2024 | 81.3% | 38.9% | 23.5% |
| 2023 | 79.2% | 31.6% | 15.4% |
| 2022 | 76.8% | 30.3% | 21.9% |
| 2021 | 74.2% | 28.0% | 19.7% |
Download Data
Export LLY earnings history in CSV or JSON format
Free sign-in required to download data
Eli Lilly and Company (LLY) Earnings Overview
As of May 6, 2026, Eli Lilly and Company (LLY) reported trailing twelve-month net income of $25.27B, reflecting +96.0% year-over-year growth. The company earned $28.21 per diluted share over the past four quarters, with a net profit margin of 31.7%.
Looking at the long-term picture, LLY's 5-year EPS compound annual growth rate (CAGR) stands at +28.8%, indicating exceptional earnings growth. The company achieved its highest annual net income of $20.64B in fiscal 2025, representing a new all-time high.
Eli Lilly and Company maintains industry-leading profitability with a gross margin of 83.8%, operating margin of 45.6%, and net margin of 31.7%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including NVO ($98.50B net income, 33.1% margin), PFE ($7.49B net income, 12.4% margin), MRK ($18.25B net income, 28.1% margin), LLY has room to improve margins relative to the peer group. Compare LLY vs NVO →
LLY Earnings vs Peers
Earnings metrics vs comparable public companies
LLY Historical Earnings Data (1989–2025)
37 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $20.64B | +94.9% | $29.70B | $22.95 | 31.7% | 45.6% |
| 2024 | $10.59B | +102.1% | $17.50B | $11.71 | 23.5% | 38.9% |
| 2023 | $5.24B | -16.1% | $10.79B | $5.80 | 15.4% | 31.6% |
| 2022 | $6.24B | +11.9% | $8.65B | $6.57 | 21.9% | 30.3% |
| 2021 | $5.58B | -9.9% | $7.93B | $5.85 | 19.7% | 28.0% |
| 2020 | $6.19B | -25.5% | $7.21B | $6.47 | 25.2% | 29.4% |
| 2019 | $8.32B | +157.4% | $6.00B | $8.69 | 37.3% | 26.9% |
| 2018 | $3.23B | +1683.5% | $6.03B | $3.13 | 15.0% | 28.0% |
| 2017 | -$204M | -107.5% | $4.25B | $-0.19 | -1.0% | 21.3% |
| 2016 | $2.74B | +13.7% | $3.87B | $2.49 | 12.9% | 18.2% |
Full LLY Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Should I Buy LLY Right Now?
Bull case, key risks, Wall St analyst verdict, and what council investors are saying — updated daily.
See LLY's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LLY Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LLY vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonLLY — Frequently Asked Questions
Quick answers to the most common questions about buying LLY stock.
Is LLY growing earnings?
LLY EPS is $28.21, with earnings growth accelerating to +96.0%. This exceeds the 5-year CAGR of +28.8%. TTM net income reached $25.3B.
What are LLY's profit margins?
Eli Lilly and Company net margin is +31.7%, with operating margin at +45.6%. Above-average margins indicate pricing power.
How consistent are LLY's earnings?
LLY earnings data spans 1989-2025. The accelerating earnings trend is +96.0% YoY. Historical data enables comparison across business cycles.